PRKAA2 and cardiac hypertrophy: Repressing mTOR signaling, metformin was able to protect mouse hearts against ventricular hypertrophy and dysfunction in both wild-type and AMPKα2 knockout mice exposed to transverse aortic constriction-induced hypertrophy [148].